Best for
All-rounder
How to buy Genus shares | 4196p
Own Genus shares in just a few minutes. Share price changes are updated daily.
Fact checked
Genus plc (GNS) is a leading biotechnology business based in the UK. It opened the day at 4320p after a previous close of 4212p. During the day the price has varied from a low of 4156p to a high of 4320p. The latest price was 4196p (25 minute delay). Genus is listed on the London Stock Exchange (LSE) and employs 3,100 staff. All prices are listed in pence sterling.
How to buy shares in Genus
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: GNS in this case.
- Research Genus shares. The platform should provide the latest information available.
- Buy your Genus shares. It's that simple.
Best for
Low-cost trading
Best for
US shares
Best for
Beginners
What's in this guide?
- Can I buy shares in Genus?
- Has coronavirus impacted Genus shares?
- Genus shares summary
- Compare share dealing platforms
- Is Genus stock a buy or sell?
- Genus performance over time
- Are Genus shares over-valued?
- Genus's financials
- How volatile are Genus shares?
- Does Genus pay a dividend?
- Other common questions
How has Coronavirus impacted Genus's share price?
Since the stock market crash in March caused by coronavirus, Genus's share price has had significant positive movement.
Its last market close was 4150p, which is 20.63% up on its pre-crash value of 3294p and 68.38% up on the lowest point reached during the March crash when the shares fell as low as 2464.6p.
If you had bought £1,000 worth of Genus shares at the start of February 2020, those shares would have been worth £927.34 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £1,347.51.
Genus share price
Use our graph to track the performance of GNS stocks over time.Genus shares at a glance
Information last updated 2020-12-18.
| Open | 4320p |
|---|---|
| High | 4320p |
| Low | 4156p |
| Close | 4196p |
| Previous close | 4212p |
| Change | -16p |
| Change % | -0.38% |
| Volume | 153,693 |
Information last updated 2020-12-27.
| 52-week range | 2532.1521p - 4485.0146p |
|---|---|
| 50-day moving average | 4152.1177p |
| 200-day moving average | 3784.2395p |
| Wall St. target price | 2332.5p |
| PE ratio | 66.9144 |
| Dividend yield | 0.29p (0.7%) |
| Earnings per share (TTM) | 61.9p |
Invest in Genus shares with 0% commission
Other fees may apply. Your capital is at risk.
- Unlimited trades, with no dealing charges or management fees
- If your trades get copied you can earn extra money
- Create an account today in a few minutes
Go to site
Capital at risk
Share dealing platform comparison
Table: sorted by promoted deals first
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is it a good time to buy Genus stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Genus price performance over time
Historical closes compared with the last close of 4196p
| 1 week (2021-01-11) | -4.24% |
|---|---|
| 1 month (2020-12-18) | 4196 |
| 3 months (2020-10-19) | 1.11% |
| 6 months (2020-07-17) | 19.75% |
| 1 year (2020-01-17) | 36.06% |
|---|---|
| 2 years (2019-01-18) | 89.69% |
| 3 years (2018-01-18) | 65.98% |
| 5 years (2016-01-18) | 201.44% |
Is Genus under- or over-valued?
Valuing Genus stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Genus's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Genus's P/E ratio
Genus's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 67x. In other words, Genus shares trade at around 67x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Genus's EBITDA
Genus's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £73.2 million.
The EBITDA is a measure of a Genus's overall financial performance and is widely used to measure a its profitability.
Genus financials
| Revenue TTM | £551.4 million |
|---|---|
| Operating margin TTM | 9.18% |
| Gross profit TTM | £211.6 million |
| Return on assets TTM | 3.78% |
| Return on equity TTM | 8.22% |
| Profit margin | 7.35% |
| Book value | 7.837p |
| Market capitalisation | £2.7 billion |
TTM: trailing 12 months
Genus share dividends
Dividend payout ratio: 4619.05% of net profits
Recently Genus has paid out, on average, around 4619.05% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.7% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Genus shareholders could enjoy a 0.7% return on their shares, in the form of dividend payments. In Genus's case, that would currently equate to about 0.29p per share.
Genus's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 19 November 2020 (the "ex-dividend date").
Genus share price volatility
Over the last 12 months, Genus's shares have ranged in value from as little as 2532.1521p up to 4485.0146p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Genus's is 0.2269. This would suggest that Genus's shares are less volatile than average (for this exchange).
Win £500 to get your trading started
Subscribe to trending stock alerts for a chance to win
Genus overview
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers semen sexing, in vitro fertilization, reproductive, and other technical services to farmers. Genus plc has a strategic porcine collaboration with Beijing Capital Agribusiness Co. Ltd to research, develop, register, and market porcine reproductive and respiratory syndrome virus resistant pigs. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.
Frequently asked questions
More guides on Finder
-
How to buy Lemonade shares | $50.05
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Unity Software shares | $111.51
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
-
How to buy FuelCell Energy shares | $3.745
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
-
How to buy CloudCommerce shares | $0.1275
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
-
How to buy Zomedica Pharmaceuticals shares | $0.93
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
-
How to buy YRC Worldwide shares | $4.66
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
-
How to buy Xeros Technology Group shares | 220p
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
-
How to buy Xpediator shares | 33.5p
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
-
How to buy Van Elle Holdings shares | 42p
Ever wondered how to buy shares in Van Elle Holdings? We explain how and compare a range of providers that can give you access to many brands, including Van Elle Holdings.
-
How to buy ULS Technology shares | 80.7p
Ever wondered how to buy shares in ULS Technology? We explain how and compare a range of providers that can give you access to many brands, including ULS Technology.
Ask an Expert